BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

323 related articles for article (PubMed ID: 23589849)

  • 1. Prognostic microRNA/mRNA signature from the integrated analysis of patients with invasive breast cancer.
    Volinia S; Croce CM
    Proc Natl Acad Sci U S A; 2013 Apr; 110(18):7413-7. PubMed ID: 23589849
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genomic instability-derived plasma extracellular vesicle-microRNA signature as a minimally invasive predictor of risk and unfavorable prognosis in breast cancer.
    Bao S; Hu T; Liu J; Su J; Sun J; Ming Y; Li J; Wu N; Chen H; Zhou M
    J Nanobiotechnology; 2021 Jan; 19(1):22. PubMed ID: 33436002
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DNA methylation contributes to deregulation of 12 cancer-associated microRNAs and breast cancer progression.
    Pronina IV; Loginov VI; Burdennyy AM; Fridman MV; Senchenko VN; Kazubskaya TP; Kushlinskii NE; Dmitriev AA; Braga EA
    Gene; 2017 Mar; 604():1-8. PubMed ID: 27998789
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of miRNA-Based Signature as a Novel Potential Prognostic Biomarker in Patients with Breast Cancer.
    Tang J; Ma W; Zeng Q; Tan J; Cao K; Luo L
    Dis Markers; 2019; 2019():3815952. PubMed ID: 31976020
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of 17 mRNAs and a miRNA as an integrated prognostic signature for lung squamous cell carcinoma.
    Zhang J; Bing Z; Yan P; Tian J; Shi X; Wang Y; Yang K
    J Gene Med; 2019 Aug; 21(8):e3105. PubMed ID: 31215090
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Systematic analysis of lncRNA-miRNA-mRNA competing endogenous RNA network identifies four-lncRNA signature as a prognostic biomarker for breast cancer.
    Fan CN; Ma L; Liu N
    J Transl Med; 2018 Sep; 16(1):264. PubMed ID: 30261893
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An eight-lncRNA signature predicts survival of breast cancer patients: a comprehensive study based on weighted gene co-expression network analysis and competing endogenous RNA network.
    Sun M; Wu D; Zhou K; Li H; Gong X; Wei Q; Du M; Lei P; Zha J; Zhu H; Gu X; Huang D
    Breast Cancer Res Treat; 2019 May; 175(1):59-75. PubMed ID: 30715658
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Construction and validation of a three-microRNA signature as prognostic biomarker in patients with hepatocellular carcinoma.
    Zhang X; Ma L; Zhai L; Chen D; Li Y; Shang Z; Zhang Z; Gao Y; Yang W; Li Y; Pan Y
    Int J Med Sci; 2021; 18(4):984-999. PubMed ID: 33456356
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Breast tissue-based microRNA panel highlights microRNA-23a and selected target genes as putative biomarkers for breast cancer.
    Eissa S; Matboli M; Shehata HH
    Transl Res; 2015 Mar; 165(3):417-27. PubMed ID: 25445205
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Integration of mRNA expression profile, copy number alterations, and microRNA expression levels in breast cancer to improve grade definition.
    Cava C; Bertoli G; Ripamonti M; Mauri G; Zoppis I; Della Rosa PA; Gilardi MC; Castiglioni I
    PLoS One; 2014; 9(5):e97681. PubMed ID: 24866763
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Circulating microRNA-based screening tool for breast cancer.
    Frères P; Wenric S; Boukerroucha M; Fasquelle C; Thiry J; Bovy N; Struman I; Geurts P; Collignon J; Schroeder H; Kridelka F; Lifrange E; Jossa V; Bours V; Josse C; Jerusalem G
    Oncotarget; 2016 Feb; 7(5):5416-28. PubMed ID: 26734993
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A nine-miRNA signature as a potential diagnostic marker for breast carcinoma: An integrated study of 1,110 cases.
    Xiong DD; Lv J; Wei KL; Feng ZB; Chen JT; Liu KC; Chen G; Luo DZ
    Oncol Rep; 2017 Jun; 37(6):3297-3304. PubMed ID: 28440475
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identifying a miRNA signature for predicting the stage of breast cancer.
    Yerukala Sathipati S; Ho SY
    Sci Rep; 2018 Oct; 8(1):16138. PubMed ID: 30382159
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An integrated mRNA and microRNA expression signature for glioblastoma multiforme prognosis.
    Xiong J; Bing Z; Su Y; Deng D; Peng X
    PLoS One; 2014; 9(5):e98419. PubMed ID: 24871302
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An Integrated miRNA-lncRNA Signature Predicts the Survival of Stage II Colon Cancer.
    Wang XJ; Zeng B; Lin S; Chen M; Chi P
    Ann Clin Lab Sci; 2019 Nov; 49(6):730-739. PubMed ID: 31882423
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Subtype-specific micro-RNA expression signatures in breast cancer progression.
    Haakensen VD; Nygaard V; Greger L; Aure MR; Fromm B; Bukholm IR; Lüders T; Chin SF; Git A; Caldas C; Kristensen VN; Brazma A; Børresen-Dale AL; Hovig E; Helland Å
    Int J Cancer; 2016 Sep; 139(5):1117-28. PubMed ID: 27082076
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel microRNAs expression signature for hepatocellular carcinoma diagnosis and prognosis.
    Lu M; Kong X; Wang H; Huang G; Ye C; He Z
    Oncotarget; 2017 Jan; 8(5):8775-8784. PubMed ID: 28060739
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel multidimensional signature predicts prognosis in hepatocellular carcinoma patients.
    Wang S; Zhang JH; Wang H; Yang L; Hong S; Yu B; Guo JC; Liu J; Zhu YB
    J Cell Physiol; 2019 Jul; 234(7):11610-11619. PubMed ID: 30480822
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Breast cancer signatures for invasiveness and prognosis defined by deep sequencing of microRNA.
    Volinia S; Galasso M; Sana ME; Wise TF; Palatini J; Huebner K; Croce CM
    Proc Natl Acad Sci U S A; 2012 Feb; 109(8):3024-9. PubMed ID: 22315424
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Construction of an initial microRNA regulation network in breast invasive carcinoma by bioinformatics analysis.
    Yin Y; Shen C; Xie P; Cheng Z; Zhu Q
    Breast; 2016 Apr; 26():1-10. PubMed ID: 27017236
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.